HN2011000404A - Derivados de enfumafungina y composicion comprendiendo los mismos - Google Patents
Derivados de enfumafungina y composicion comprendiendo los mismosInfo
- Publication number
- HN2011000404A HN2011000404A HN2011000404A HN2011000404A HN2011000404A HN 2011000404 A HN2011000404 A HN 2011000404A HN 2011000404 A HN2011000404 A HN 2011000404A HN 2011000404 A HN2011000404 A HN 2011000404A HN 2011000404 A HN2011000404 A HN 2011000404A
- Authority
- HN
- Honduras
- Prior art keywords
- compounds
- enfumafungina
- understanding
- same
- derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/64—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
- A01N43/647—Triazoles; Hydrogenated triazoles
- A01N43/653—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Pest Control & Pesticides (AREA)
- Environmental Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Agronomy & Crop Science (AREA)
- Oncology (AREA)
- Plant Pathology (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Cosmetics (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A NOVEDOSOS DERIVADOS DE ENFUMAFUNGINA, JUNTO CON SUS SALES, HIDRATOS Y PORDROGAS FARMACEUTICAMENTE ACEPTABLES. TAMBIEN SE DESCRIBEN COMPOSICIONES QUE COMPRENDEN DICHOS COMPUESTOS, METODOS PARA PREPARAR DICHOS COMPUESTOS Y METODOS PARA USAR DICHOS COMPUESTOS COMO AGENTES ANTIFUNGICOS Y/O INHIBIDORES DE (1,3)-b-D-glucan SINTASA. LOS COMPUESTOS DESCRIPTOS, SUS SALES HIDRATOS Y PRODROGAS FARMACEUTICAMENTE ACEPTABLES, ASI COMO LAS COMPOSICIONES QUE COMPRENDEN DICHAS SALES, HIDRATOS Y PRODROGAS, SON UTILES PARA TRATAR Y/O PREVENIR INFECCIONES FUNGICAS Y ENFERMEDADES Y AFECCIONES ASOCIADAS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13610608P | 2008-08-12 | 2008-08-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
HN2011000404A true HN2011000404A (es) | 2013-09-23 |
Family
ID=41669132
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HN2011000404A HN2011000404A (es) | 2008-08-12 | 2011-02-11 | Derivados de enfumafungina y composicion comprendiendo los mismos |
Country Status (31)
Country | Link |
---|---|
EP (1) | EP2326172B1 (es) |
KR (1) | KR101686075B1 (es) |
AR (1) | AR073037A1 (es) |
BR (1) | BRPI0912074B1 (es) |
CL (1) | CL2011000292A1 (es) |
CO (1) | CO6351686A2 (es) |
CR (1) | CR20110075A (es) |
DK (1) | DK2326172T3 (es) |
DO (1) | DOP2011000053A (es) |
EA (1) | EA018337B1 (es) |
ES (1) | ES2526652T3 (es) |
GT (1) | GT201100039A (es) |
HK (1) | HK1158017A1 (es) |
HN (1) | HN2011000404A (es) |
HR (1) | HRP20150009T1 (es) |
IL (2) | IL210975A (es) |
MA (1) | MA32628B1 (es) |
MX (1) | MX2011001656A (es) |
MY (1) | MY156955A (es) |
NI (1) | NI201100035A (es) |
NZ (1) | NZ590914A (es) |
PE (1) | PE20110676A1 (es) |
PL (1) | PL2326172T3 (es) |
PT (1) | PT2326172E (es) |
RS (1) | RS53731B1 (es) |
SI (1) | SI2326172T1 (es) |
SV (1) | SV2011003839A (es) |
TW (1) | TWI439458B (es) |
UA (1) | UA105639C2 (es) |
WO (1) | WO2010019203A1 (es) |
ZA (1) | ZA201100788B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HRP20220544T1 (hr) * | 2015-01-19 | 2022-08-05 | Scynexis, Inc. | Nove soli i polimorfi scy-078 |
JP7263313B2 (ja) * | 2017-04-10 | 2023-04-24 | サイネクシス,インコーポレーテッド | 併用される抗真菌剤 |
JP7214714B2 (ja) * | 2017-08-04 | 2023-01-30 | サイネクシス,インコーポレーテッド | 酸性pHで活性の増強を示す抗真菌剤 |
MA54866A (fr) * | 2019-01-30 | 2022-05-04 | Scynexis Inc | Antifongiques triterpénoïdes pour le traitement d'infections ostéoarticulaires fongiques |
CA3140637A1 (en) * | 2019-05-16 | 2020-11-19 | Scynexis, Inc. | Antifungal agents, like ibrexafungerp for candida auris decolonization |
EP4157356A1 (en) | 2020-05-29 | 2023-04-05 | Centre National de la Recherche Scientifique | Antifungal prodrugs |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5756472A (en) | 1996-01-31 | 1998-05-26 | Merck & Co., Inc. | Antifungal agent obtained from hormonema |
WO1997027860A1 (en) * | 1996-01-31 | 1997-08-07 | Merck & Co., Inc. | Antifungal agent |
CN1705657A (zh) * | 2002-04-17 | 2005-12-07 | 兰贝克赛实验室有限公司 | 作为抗真菌剂的吡咯衍生物 |
EP2007396B1 (en) | 2006-04-03 | 2013-02-13 | Merck Sharp & Dohme Corp. | Enfumafungin derivatives as antifungal agents |
-
2009
- 2009-08-07 EA EA201100350A patent/EA018337B1/ru unknown
- 2009-08-07 ES ES09806944.6T patent/ES2526652T3/es active Active
- 2009-08-07 UA UAA201102860A patent/UA105639C2/uk unknown
- 2009-08-07 MY MYPI2011000483A patent/MY156955A/en unknown
- 2009-08-07 NZ NZ590914A patent/NZ590914A/en unknown
- 2009-08-07 WO PCT/US2009/004557 patent/WO2010019203A1/en active Application Filing
- 2009-08-07 PE PE2011000156A patent/PE20110676A1/es active IP Right Grant
- 2009-08-07 BR BRPI0912074-2A patent/BRPI0912074B1/pt active IP Right Grant
- 2009-08-07 SI SI200931102T patent/SI2326172T1/sl unknown
- 2009-08-07 RS RS20150006A patent/RS53731B1/en unknown
- 2009-08-07 KR KR1020117005837A patent/KR101686075B1/ko active IP Right Grant
- 2009-08-07 PT PT98069446T patent/PT2326172E/pt unknown
- 2009-08-07 MX MX2011001656A patent/MX2011001656A/es active IP Right Grant
- 2009-08-07 EP EP09806944.6A patent/EP2326172B1/en active Active
- 2009-08-07 PL PL09806944T patent/PL2326172T3/pl unknown
- 2009-08-07 DK DK09806944.6T patent/DK2326172T3/da active
- 2009-08-10 TW TW098126822A patent/TWI439458B/zh active
- 2009-08-12 AR ARP090103123A patent/AR073037A1/es active IP Right Grant
-
2011
- 2011-01-31 ZA ZA2011/00788A patent/ZA201100788B/en unknown
- 2011-01-31 IL IL210975A patent/IL210975A/en active IP Right Grant
- 2011-02-08 CR CR20110075A patent/CR20110075A/es unknown
- 2011-02-10 NI NI201100035A patent/NI201100035A/es unknown
- 2011-02-11 CO CO11016262A patent/CO6351686A2/es active IP Right Grant
- 2011-02-11 GT GT201100039A patent/GT201100039A/es unknown
- 2011-02-11 HN HN2011000404A patent/HN2011000404A/es unknown
- 2011-02-11 DO DO2011000053A patent/DOP2011000053A/es unknown
- 2011-02-11 SV SV2011003839A patent/SV2011003839A/es active IP Right Grant
- 2011-02-11 CL CL2011000292A patent/CL2011000292A1/es unknown
- 2011-03-11 MA MA33691A patent/MA32628B1/fr unknown
- 2011-11-23 HK HK11112674.5A patent/HK1158017A1/xx unknown
-
2015
- 2015-01-07 HR HRP20150009AT patent/HRP20150009T1/hr unknown
- 2015-10-12 IL IL242031A patent/IL242031A0/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GT200900027A (es) | Compuestos organicos | |
GT200800158A (es) | Pirazolquinolonas como potentes inhibidores de parp | |
CL2011001658A1 (es) | Compuestos derivados de sulfonamidas, moduladores de los canales de sodio; composición farmacéutica que los comprende; y su uso en el tratamiento del dolor. | |
UY30498A1 (es) | Nueva clase de compuestos de benzimidazolilo, sus sales, composiciones farmacéuticas conteniéndolos y aplicaciones | |
CR10148A (es) | Derivados de las benzamidas y heteroarenos | |
GT200800184A (es) | Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa-iv para el tratamiento o prevencion de diabetes. | |
UY31806A (es) | Compuestos de tiazole y oxazole de sulfonamida de benceno | |
UY30314A1 (es) | Derivados de benzonitrilo sustituidos con glucopiranosilo, composiciones farmacéuticas que contienen compuestos de este tipo, su uso y procedimiento para su fabricacion | |
CR20110016A (es) | Compuestos quimicos 251 | |
UY29360A1 (es) | Nuevos derivados de pirazol, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones. | |
PA8667201A1 (es) | Nuevos compuestos farmaceuticos | |
SV2009003307A (es) | Quinazolinas para la inhibicion de pdk1 | |
UY30846A1 (es) | Derivados de oxindol sustituidos, medicamentos que los comprenden y uso de los mismos | |
UY31481A1 (es) | Nuevos derivados de pirimidina, procesos de preparacion, composiciones farmacéuticas conteniéndolos y aplicaciones | |
PA8842101A1 (es) | Heteroarilos sustituidos | |
CR10304A (es) | Compuestos de tetrahidropiridotienopirimidina y procedimientos de uso de los mismos | |
DOP2010000134A (es) | Algunos derivados de 2-pirazinona como inhibidores de elastasa de los neutrofilos | |
GT200600161A (es) | Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de los trastornos psicoticos | |
CR10573A (es) | Derivados del pirazol como inhibidores del citocromo p450 | |
GT200800285A (es) | Aminopirazolopiridinas sustituidas y sus sales, sus preparaciones y composiciones farmaceuticas que las comprenden | |
CR9786A (es) | Compuestos de bencimidazol-tiofeno | |
SV2010003650A (es) | INHIBIDORES HETEROCICLICOS DE ESTEAROIL-CoA-DESATURASA | |
DOP2009000165A (es) | Derivados de oxindol sustituido, medicamentos que los comprenden y uso de los mismos | |
UY33655A (es) | Co-cristales y sales de inhibidores de ccr30 | |
CO6382089A2 (es) | Compuestos,composiciones y metodos para el tratamiento de enfermadades causadas por un b-amiloide y sinucleinopatias |